These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Antidiabetic and anticoagulant properties of the heparin-glutamic acid complex]. Ul'ianov AM; Liapina LA; Pastorova VE; Smolina TIu Izv Akad Nauk Ser Biol; 2004; (3):340-4. PubMed ID: 15354961 [TBL] [Abstract][Full Text] [Related]
8. Effect of heparin on antigen-induced airway responses and pulmonary leukocyte accumulation in neonatally immunized rabbits. Preuss JM; Page CP Br J Pharmacol; 2000 Apr; 129(8):1585-96. PubMed ID: 10780962 [TBL] [Abstract][Full Text] [Related]
9. The effect of priscoline upon normal and diabetic glycemia. GOLDNER MG; ZAROWITZ H Am J Med Sci; 1953 Nov; 226(5):546-51. PubMed ID: 13104408 [No Abstract] [Full Text] [Related]
10. [The effect of heparin on the level of sugar and lipids in the blood in diabetic patients]. Bozadzhieva ; V'rbanov G Probl Endokrinol Gormonoter; 1966; 12(4):45-8. PubMed ID: 6002013 [No Abstract] [Full Text] [Related]
11. [Effect of heparin on the Mg++-ATPase of the muscle mitochondria of adult and young rabbits]. Dubinina EE Vopr Med Khim; 1975; 21(2):128-31. PubMed ID: 124504 [TBL] [Abstract][Full Text] [Related]
12. [Influence of isoptin on the anticoagulant effect of the sodium and calcium salts of heparin]. Ushkalova EA; Kremneva VF; Shcheglova NV Farmakol Toksikol; 1988; 51(3):48-51. PubMed ID: 3410026 [TBL] [Abstract][Full Text] [Related]
13. [Influence of bigumal on the blood coagulation system and on the anticoagulant effect of heparin]. kremneva VF; Ushkalova EA; Shcheglova NV Farmakol Toksikol; 1986; 49(6):43-5. PubMed ID: 3817142 [TBL] [Abstract][Full Text] [Related]
14. [Effect of heparin, heparin derivatives and heparinoids on blood sugar levels of diabetes mellitus patients]. Bozadzhieva EK; Markovski SG Probl Endokrinol (Mosk); 1978; 24(6):23-30. PubMed ID: 82965 [TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the effects of 4-chlorophenyl-2-hydroxy-4-oxo-2-butenoate and heparin on blood coagulation]. Starkova AV; Sobin FB; Syropiatov BIa; Pulina NA Eksp Klin Farmakol; 2013; 76(10):25-6. PubMed ID: 24400385 [TBL] [Abstract][Full Text] [Related]
16. Kallikrein-kinin system of blood plasma on heterotransfusion backed by the use of heparin. Vygovskaya YI; Vorobel AV; Buzherak NF Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):716-24. PubMed ID: 6198255 [TBL] [Abstract][Full Text] [Related]
17. [The influence of ciprofloxacin and pefloxacin on blood coagulation and the anticoagulant effect of heparin]. Lepakhin VK; Ushkalova EA; Shcheglova NV Farmakol Toksikol; 1989; 52(5):33-6. PubMed ID: 2599074 [TBL] [Abstract][Full Text] [Related]
18. [Role of heparin in the realization of the hypoglycemic action of insulin]. Kudriashov BA; Ul'ianov AM; Shapiro FB; Bazaz'ian GG; Pytel' IuA Biull Eksp Biol Med; 1984 May; 97(5):516-8. PubMed ID: 6372894 [TBL] [Abstract][Full Text] [Related]
19. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin]. Shevchenko LV; Ovchinnikova LK; Zolotukhin SI Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373 [TBL] [Abstract][Full Text] [Related]
20. The use of protease inhibitor (trasylol) and heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting system. Gaszyński W Anaesth Resusc Intensive Ther; 1975; 3(2):125-34. PubMed ID: 1080969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]